| News
Welcome to the Basel region: Cerdia
30.04.2019
Cerdia’s history starts with Rhodia Acetow more than 100 years ago: The company was founded in 1912 in the Rhone valley in France. Its specialty were polyester and nylon textiles. Later, Rhodia Acetow developed huge business opportunities in producing cigarette filter tow and cellulose acetate. In 2018, the company opened a new chapter in their books: The international headquarters were moved from Freiburg i.B., Germany to Basel. The new stand-alone entity in Basel was rebranded Cerdia in March 2019. Today, Cerdia has an annual turnover of more than 600 million Swiss francs. 1300 employees work for the company with hubs in France, Singapore, the US, Brazil and Russia.
Philippe Rosier, CEO Cerdia (img: Pino Covino)
From tow to timber
The acetate specialists are well-known for their innovative products such as filter tow for IQOS cigarettes, filter tow for super slim cigarettes, coloured or biodegradable tow. While global cigarette consumption is in decline, the application range for acetylation is not: Cerdia promotes a durable timber range under the name Accoya, licensed from the British Accsys Group: Wood acetylation alters the timber, making it more durable and reducing its ability to absorb water by approximately 80 percent. The processed wood is safe from rot, mould and fungi, yet bendable, non-toxic and 100 percent recyclable, making it applicable for façades as well as window frames or outdoor furniture.
Make Cerdia more international
The new positioning reflects the transformation of the company, says Philippe Rosier, CEO of Cerdia: “We chose Basel for our new corporate headquarters to transform the culture of the company from here and make Cerdia more international.” The company set up their management offices in a carefully renovated town house in Basel. Philippe Rosier: “The BaselArea.swiss team did a great job finding this wonderful location and supported us with the administrative part of the transition.” Basel not only offers Cerdia proximity to tobacco companies in Switzerland and a spot within the community of global pharma companies, but also access to the vast network of architectural firms that are settled in the area – optimal for developing the market for Accoya timber.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Yokogawa establishes innovation center in Allschwil
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.
Read More
Basel gains new biotech in Bright Peak
Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.
Read More
Robots from Basel set to revolutionize surgery
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.
Read More
T3 Pharma raises over 25 million Swiss francs
T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.
Read More
Versameb raises 6 million Swiss francs
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.
Read More
Genedata accelerating drug development
Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.
Read More
Basel is “probably the most productive life sciences location in the world”
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.
Read More
Basel Area cantons publish joint economic report
The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.
Read More
Resistell receives high-level EU grant
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.
Read More
Switzerland Innovation Park Basel Area Site Novartis Campus
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.
Read More
